Home › Macular Edema › New York
Macular Edema clinical trials in New York
3 studies for Macular Edema are looking for participants at sites in New York.
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Retina Associates of Western NY, PC ( Site 0038), Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07705555A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
- Retina Associates of New York, P.C., New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
- Retina Associates of New York, P.C., New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06996080From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.